One- and two-day dosing intervals between mifepristone and misoprostol in second trimester medical termination of pregnancy—a randomized trial

By Mentula Maarit   Suhonen Satu   Heikinheimo Oskari  

Human Reproduction, Vol. 26, Iss. 10, 2011-10 ,pp. : 2690-2697

Oxford University Press

Access to resources Recommend Favorite

A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13–20 weeks gestation

By Hamoda Haitham   Ashok Premila W.   Flett Gillian M.M.   Templeton Allan  

Human Reproduction, Vol. 20, Iss. 8, 2005-08 ,pp. : 2348-2354

Oxford University Press

Access to resources Recommend Favorite

Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial

By von Hertzen Helena   Piaggio Gilda   Wojdyla Daniel   Huong Nguyen Thi My   Marions Lena   Okoev Georgy   Khomassuridze Archil   Kereszturi Attila   Mittal Suneeta   Nair Rajasekharan   Daver Rekha   Pretnar-Darovec Alenka   Dickson Kim   Hinh Nguyen Duc   Bao Nguyen Huy   Tuyet Hoang Thi Diem   Peregoudov Alexandre  

Human Reproduction, Vol. 24, Iss. 1, 2009-01 ,pp. : 106-112

Oxford University Press

Access to resources Recommend Favorite

Pregnancy and obstetrics. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial

By Wong K.S.  

Human Reproduction, Vol. 15, Iss. 3, 2000-03 ,pp. : 709-712

Oxford University Press

Access to resources Recommend Favorite

A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12–20 weeks gestation

By Tang Oi Shan   Chan Carina C.W.   Kan Anita S.Y.   Ho Pak Chung  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3062-3066

Oxford University Press

Access to resources Recommend Favorite